Pay in 4 interest-free payments of $26.25 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
Substance P
Formula: C18H24O3
A phase I study of tasisulam sodium using an albumin-tailored dose in Japanese patients with advanced solid tumors
also known as (R)-Baclofen
InChi: InChI=1S/C20H15ClF3N5
TAK-779 Catalog No.:M10030-10 Substance PTAK 779 is a C C chemokine receptor type 5 (CCR5) receptor antagonist potentially for the treatment of HIV infection. Treatment with TAK 779 reduced incidence and severity of experimental autoimmune encephalomyelitis. It strongly inhibited migration of CXCR3 CCR5 bearing CD4+, CD8+ and CD11b+ leukocytes to the CNS. TAK 779 did not reduce proliferation of anti myelin oligodendrocyte glycoprotein T cells, the production of IFN gamma by T cells or CXCR3